Article

The carnosinase dipeptidase CNDP1 is a novel metabolic vulnerability in brain metastasis

medRxiv · 2025 · Gomez-Munoz, M. A.; Karz, A.; Navarro, M.; Osorio-Vasquez, V. M.; Katsara, O.; Walker, A.; Berico, P.; Medellin, A. P.; Eskow, N. M.; Wan, Y.; Ibrahim, M.; Tagore, S.; DSouza, E. K.; Izar, B.; Vega-Saenz de Miera, E.; Osman, I.; Pacold, M.; Kong, X.; Levesque, M.; Possemato, R.; Holmen, S.; Schneider, R.; Vincent, T.; Ruggles, K.; Biancur, D.; Hernando, E.

Key facts

Title The carnosinase dipeptidase CNDP1 is a novel metabolic vulnerability in brain metastasis
First author Gomez-Munoz, M. A.; Karz, A.; Navarro, M.; Osorio-Vasquez, V. M.; Katsara, O.; Walker, A.; Berico, P.; Medellin, A. P.; Eskow, N. M.; Wan, Y.; Ibrahim, M.; Tagore, S.; DSouza, E. K.; Izar, B.; Vega-Saenz de Miera, E.; Osman, I.; Pacold, M.; Kong, X.; Levesque, M.; Possemato, R.; Holmen, S.; Schneider, R.; Vincent, T.; Ruggles, K.; Biancur, D.; Hernando, E.
Journal medRxiv
Published Jan 1, 2025
DOI 10.1101/2025.03.18.644053
Devices mentioned 017655, 018737, 018938, 021752, K010696, K073490, K802418, K935809, K951821
Product codes mentioned CEK, CFN, GIA, GQH, JCJ, JJH, JJQ, JJX, JQW, LIN, LXG, MVU and 5 more

At a glance

  • 1–9 FDA submissions mentioned
  • 10–99 Product codes mentioned

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About Literature

Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.

Source: Publisher and PubMed metadata; device mentions identified by Orca1

Browse all Literature